{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["7"],"submitter":["Ross S"],"pubmed_abstract":["<h4>Background</h4>In 2006, Ethicon Inc. introduced a new minimally invasive single incision sling device for the surgical treatment of stress urinary incontinence, the Gynecare TVT Secur®. For device licensing, no new evidence of TVT Secur efficacy and safety was needed: rather evidence was provided of the long-term follow-up of patients who had a procedure using a predecate retropubic tension-free vaginal tape device. Before adopting TVT Secur into our routine clinical practice, we decided to evaluate it. The objective of our Canadian multi-centre pragmatic randomized controlled trial was to compare the effectiveness of the new single-incision device, TVT Secur, to the established TVT device, in terms of objective cure of stress urinary incontinence (SUI) at 12 months postoperatively. Ot"],"journal":["BMC research notes"],"pagination":["941"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4307185"],"repository":["biostudies-literature"],"pubmed_title":["Single incision device (TVT Secur) versus retropubic tension-free vaginal tape device (TVT) for the management of stress urinary incontinence in women: a randomized clinical trial."],"pmcid":["PMC4307185"],"pubmed_authors":["Goncalves J","Schulz J","Murphy M","Tang S","Dederer L","Robert M","Ross S","Kaye S"],"additional_accession":[]},"is_claimable":false,"name":"Single incision device (TVT Secur) versus retropubic tension-free vaginal tape device (TVT) for the management of stress urinary incontinence in women: a randomized clinical trial.","description":"<h4>Background</h4>In 2006, Ethicon Inc. introduced a new minimally invasive single incision sling device for the surgical treatment of stress urinary incontinence, the Gynecare TVT Secur®. For device licensing, no new evidence of TVT Secur efficacy and safety was needed: rather evidence was provided of the long-term follow-up of patients who had a procedure using a predecate retropubic tension-free vaginal tape device. Before adopting TVT Secur into our routine clinical practice, we decided to evaluate it. The objective of our Canadian multi-centre pragmatic randomized controlled trial was to compare the effectiveness of the new single-incision device, TVT Secur, to the established TVT device, in terms of objective cure of stress urinary incontinence (SUI) at 12 months postoperatively. Ot","dates":{"release":"2014-01-01T00:00:00Z","publication":"2014 Dec","modification":"2025-04-19T02:07:35.073Z","creation":"2019-03-27T01:44:07Z"},"accession":"S-EPMC4307185","cross_references":{"pubmed":["25532604"],"doi":["10.1186/1756-0500-7-941"]}}